Background: Genetic background plays a role in multiple myeloma susceptibility. Several
single-nucleotide polymorphisms (SNP) associated with genetic susceptibility to multiple …

Previous researches exploring associations between multiple myeloma (MM) and genetic
polymorphisms showed controversial results. In this investigation, we aimed to make a meta …

There is overwhelming epidemiologic evidence that the risk of multiple myeloma (MM) has a
solid genetic background. Genome-wide association studies (GWAS) have identified 23 risk …

Background: Genome-wide association studies (GWAS) of multiple myeloma in populations
of European ancestry (EA) identified and confirmed 24 susceptibility loci. For other cancers …

Background: Genome-wide association studies (GWAS) in European populations have
identified genetic risk variants associated with multiple myeloma. Methods: We performed …

Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis.
Genome-wide association studies have transformed our understanding of MM …

The etiology of multiple myeloma (MM) is poorly understood. Summary data from genome-
wide association studies (GWASs) of multiple phenotypes can be exploited in a Mendelian …

While the etiology of multiple myeloma (MM) is largely unknown, evidence for an inherited
genetic susceptibility is provided by the two-fold increased risk of the disease seen in first …

There is strong evidence suggesting the presence of a genetic component in the aetiology of
multiple myeloma (MM). However no genetic risk factors have been unequivocally …

Multiple myeloma (MM) is the second most common haematological cancer after non-
Hodgkin lymphoma (Raab et al, 2009), with a worldwide age-standardized rate of 1Á5/100 …